Oragenics (OGEN) Other Non Operating Income (2010 - 2026)
Oragenics' (OGEN) quarterly Other Non Operating Income came in at -$5090.0 in Q1 2026, down 176.33% YoY from $6668.4 in Q1 2025, and up 0.51% on a QoQ basis from -$5116.0 in Q4 2025.
Oragenics (OGEN) Other Non Operating Income (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 14 years of Other Non Operating Income data on file, last reported at -$5090.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 176.33% year-over-year to -$5090.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16441.0 (up 31.87% YoY) and the FY2025 annual result came in at -$13193.0, up 47.59% from the prior year.
- Other Non Operating Income improved to -$5090.0 in Q1 2026, from -$5116.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $45118.0 in Q3 2023 to a low of -$25085.0 in Q3 2024.
- A 5-year average of $2343.2 and a median of -$796.5 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income soared 8936.14% — and 2024, when it tumbled 694.52%.
- Tracing OGEN's Other Non Operating Income over 5 years: stood at $249.0 in 2022, then soared by 8936.14% to $22500.0 in 2023, then slumped by 71.17% to $6487.0 in 2024, then sank by 178.87% to -$5116.0 in 2025, then advanced by 0.51% to -$5090.0 in 2026.
- The last three Other Non Operating Income figures came in at -$5090.0 (Q1 2026), -$5116.0 (Q4 2025), and -$3919.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12,168.00 |
| Mar 31, 2026 | -5,090.00 |
| Dec 31, 2025 | -5,116.00 |
| Sep 30, 2025 | -3,919.00 |
| Jun 30, 2025 | -2,316.00 |
| Mar 31, 2025 | -1,842.00 |
| Dec 31, 2024 | 6,487.00 |
| Sep 30, 2024 | -25,085.00 |
| Jun 30, 2024 | -3,692.00 |
| Mar 31, 2024 | -2,880.00 |
| Dec 31, 2023 | 22,500.00 |
| Sep 30, 2023 | 45,118.00 |
| Jun 30, 2023 | 621.00 |
| Mar 31, 2023 | 1,124.00 |
| Dec 31, 2022 | 249.00 |
| Jun 30, 2022 | 369.00 |
| Mar 31, 2022 | 10,964.00 |
| Mar 31, 2021 | 670.00 |
| Mar 31, 2020 | 1,795.00 |
| Dec 31, 2017 | 1.00 |